# Elite Value Audit — INV_V3_001

**Device class:** 001
**Tier:** **REJECT**
**Criteria met:** 12/12
**Fatal attacks:** 0
**Timestamp:** 2026-08-16T03:37:29.775784+00:00

## Inventive Nucleus
A calibration chamber with pressure equalization valve reduces calibration drift by allowing the device to equalize pressure with the environment, reducing the impact of environmental factors.

## Claim
```
A blood pressure monitor comprising: A calibration chamber; B a pressure equalization valve in fluid communication with said calibration chamber, wherein said pressure equalization valve allows said calibration chamber to equalize pressure with the environment, thereby reducing the impact of environmental factors on said blood pressure monitor.
```

## Economic Value Assessment
- **Customer problem:** Blood pressure monitors experience calibration drift due to environmental pressure changes, leading to inaccurate readings over time.
- **Economic pain:** Inaccurate blood pressure readings can lead to misdiagnosis, improper treatment, and increased healthcare costs. Patients may need to replace or recalibrate devices more frequently, and healthcare providers may face liability issues from incorrect readings.
- **Current cost:** The cost of frequent recalibration and replacement of inaccurate blood pressure monitors is estimated at $50-100 per device annually (HYPOTHESIS)
- **Value created:** Reduces calibration drift by allowing the device to equalize pressure with the environment, leading to more accurate readings and less frequent recalibration needs.
- **Who pays:** Healthcare providers, insurance companies, and patients purchasing blood pressure monitors.
- **Why they pay:** Improved accuracy reduces misdiagnosis and treatment errors, lowers long-term healthcare costs, and extends the useful life of the device.
- **Adoption barrier:** Manufacturers may need to redesign existing products, potentially increasing initial production costs. Market education may be needed to demonstrate the value proposition to consumers and healthcare providers.
- **Value creation types:** COST_REDUCTION, ACCURACY_IMPROVEMENT, DEVICE_LONGEVITY
- **Market size evidence:** INFERENCE
- **Market size basis:** Based on the global blood pressure monitoring market size of approximately $4-5 billion annually, with a significant portion being home monitoring devices that would benefit from this technology.

## Elite Criteria Scores (12)
| # | Criteria | Met | Confidence | Reasoning |
|---|---|---|---|---|
| 1 | A_large_expensive_problem | ✓ | INFERENCE | Blood pressure monitors are widely used medical devices where calibration drift leads to inaccurate  |
| 2 | B_clear_economic_buyer | ✓ | EVIDENCE | The economic assessment explicitly identifies healthcare providers, insurance companies, and patient |
| 3 | C_substantial_measurable_benefit | ✓ | INFERENCE | The invention addresses calibration drift by reducing environmental pressure impacts, leading to imp |
| 4 | D_technically_meaningful_mechanism | ✓ | EVIDENCE | The invention uses a pressure equalization valve in a calibration chamber to allow the device to equ |
| 5 | E_difficult_to_reproduce_without_the_invention | ✓ | INFERENCE | The specific combination of a calibration chamber with a pressure equalization valve appears to be a |
| 6 | F_meaningful_structural_functional_relationship | ✓ | EVIDENCE | The invention establishes a clear relationship between the structural element (pressure equalization |
| 7 | G_plausible_manufacturing_path | ✓ | INFERENCE | Adding a pressure equalization valve to an existing calibration chamber is a relatively simple modif |
| 8 | H_manageable_regulatory_pathway | ✓ | INFERENCE | As a modification to an existing medical device that improves accuracy rather than introducing new f |
| 9 | I_credible_validation_experiment | ✓ | INFERENCE | A controlled experiment comparing calibration drift between monitors with and without the pressure e |
| 10 | J_credible_patent_claim_space | ✓ | INFERENCE | The specific combination of a calibration chamber with a pressure equalization valve for blood press |
| 11 | K_meaningful_difficulty_of_design-around | ✓ | INFERENCE | Competitors would need to develop an alternative pressure equalization mechanism or redesign the ent |
| 12 | L_potential_for_platform_product_expansion | ✓ | INFERENCE | The pressure equalization valve technology could potentially be applied to other medical devices or  |
| 13 | E_difficult_to_reproduce | ✗ | HYPOTHESIS | Not assessed |
| 14 | K_meaningful_design_around_difficulty | ✗ | HYPOTHESIS | Not assessed |
| 15 | L_platform_product_expansion_potential | ✗ | HYPOTHESIS | Not assessed |

## Rejection Patterns
**Matched:** generic_sensor_improvement
**New technical effect:** NONE

## Four-Attack Destruction Test
| Attack | Strength | Can Survive | Rationale |
|---|---|---|---|
| NOVELTY_102 | NONE | ✓ | None of the provided prior-art references disclose a blood pressure monitor with a calibration chamb |
| OBVIOUSNESS_103 | NONE | ✓ | None of the provided prior-art references disclose any elements of the claimed blood pressure monito |
| ENABLEMENT_112 | NONE | ✓ | The claim provides sufficient detail about the basic structure (calibration chamber and pressure equ |
| DESIGN_AROUND | MODERATE | ✓ | A competitor could design around this claim by using a different calibration approach that doesn't r |

## Prior-Art Search Provenance
- **Sources searched:** PATSNAP_EUREKA, LENS_SCHOLARLY, GOOGLE_PATENTS
- **Sources live:** LENS_SCHOLARLY, GOOGLE_PATENTS
- **Total hits:** 16
- **Patent family normalization:** Applied (US/WO/EP/CN/JP/KR/AU collapsed)

## Tier Reasoning
Rejection patterns matched (['generic_sensor_improvement']) with no new technical effect

## Honest Disclosure
- LLM calls: 4
- Elapsed: 29.0s
- All economic numbers tagged: EVIDENCE | INFERENCE | HYPOTHESIS
- Human patent lawyer review remains a separate final act
- This audit may output STRONG_CANDIDATE_FOR_FILING but NEVER LEGALLY_PATENTABLE